Helen E. Scott

1.9k total citations
20 papers, 916 citations indexed

About

Helen E. Scott is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Helen E. Scott has authored 20 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Helen E. Scott's work include Prostate Cancer Treatment and Research (6 papers), Epigenetics and DNA Methylation (5 papers) and Prion Diseases and Protein Misfolding (3 papers). Helen E. Scott is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Epigenetics and DNA Methylation (5 papers) and Prion Diseases and Protein Misfolding (3 papers). Helen E. Scott collaborates with scholars based in United Kingdom, Norway and United States. Helen E. Scott's co-authors include V. Hugh Perry, David E. Neal, Colm Cunningham, Anne Y. Warren, Delphine Boche, Ian G. Mills, Charles Massie, Rory Stark, Naomi L. Sharma and Antonio Ramos‐Montoya and has published in prestigious journals such as Nucleic Acids Research, The EMBO Journal and Cancer Cell.

In The Last Decade

Helen E. Scott

19 papers receiving 901 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen E. Scott United Kingdom 14 569 315 202 179 129 20 916
Hassan Chaı̈b United States 16 638 1.1× 101 0.3× 130 0.6× 94 0.5× 137 1.1× 26 1.1k
Seungyeul Yoo United States 14 587 1.0× 123 0.4× 184 0.9× 114 0.6× 110 0.9× 26 944
Tang Zhu Canada 19 603 1.1× 251 0.8× 88 0.4× 38 0.2× 68 0.5× 29 1.2k
Ying-Wooi Wan United States 10 610 1.1× 88 0.3× 334 1.7× 241 1.3× 65 0.5× 10 1.1k
Virginie Firlej France 13 576 1.0× 188 0.6× 191 0.9× 44 0.2× 167 1.3× 26 968
Rosaria Strammiello Italy 18 1.0k 1.8× 185 0.6× 73 0.4× 467 2.6× 93 0.7× 22 1.3k
Chen Huang China 15 340 0.6× 122 0.4× 99 0.5× 40 0.2× 144 1.1× 53 807
Alonso Martínez Colombia 10 965 1.7× 169 0.5× 202 1.0× 46 0.3× 138 1.1× 22 1.4k
Leonard Kusdra United States 9 370 0.7× 165 0.5× 98 0.5× 178 1.0× 201 1.6× 11 953
Sripriya Ranganathan United States 10 455 0.8× 55 0.2× 205 1.0× 56 0.3× 165 1.3× 13 945

Countries citing papers authored by Helen E. Scott

Since Specialization
Citations

This map shows the geographic impact of Helen E. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen E. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen E. Scott more than expected).

Fields of papers citing papers by Helen E. Scott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen E. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen E. Scott. The network helps show where Helen E. Scott may publish in the future.

Co-authorship network of co-authors of Helen E. Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Helen E. Scott. A scholar is included among the top collaborators of Helen E. Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen E. Scott. Helen E. Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rooney, Timothy P. C., Helen E. Scott, Henriëtte M. G. Willems, et al.. (2025). Development of the Pyrido[2,3-d]pyrimidin-7(8H)-one Scaffold toward Potent and Selective NUAK1 Inhibitors. ACS Medicinal Chemistry Letters. 16(2). 327–335.
2.
Economopoulos, Vasiliki, et al.. (2022). Inhibition of Anti-Inflammatory Macrophage Phenotype Reduces Tumour Growth in Mouse Models of Brain Metastasis. Frontiers in Oncology. 12. 850656–850656. 7 indexed citations
3.
Soto, Manuel Sarmiento, James R. Larkin, Chris Martin, et al.. (2020). STAT3-Mediated Astrocyte Reactivity Associated with Brain Metastasis Contributes to Neurovascular Dysfunction. Cancer Research. 80(24). 5642–5655. 27 indexed citations
4.
Tran, Maxine, B. Bibby, Lingjian Yang, et al.. (2020). Independence of HIF1a and androgen signaling pathways in prostate cancer. BMC Cancer. 20(1). 469–469. 28 indexed citations
5.
Wu, Xiaoning, Helen E. Scott, Sigrid Carlsson, et al.. (2019). Increased EZH2 expression in prostate cancer is associated with metastatic recurrence following external beam radiotherapy. The Prostate. 79(10). 1079–1089. 30 indexed citations
6.
Grošelj, Blaž, Helen E. Scott, Judith Nicholson, et al.. (2017). Radiosensitization In Vivo by Histone Deacetylase Inhibition with No Increase in Early Normal Tissue Radiation Toxicity. Molecular Cancer Therapeutics. 17(2). 381–392. 29 indexed citations
7.
Kerr, Martin, Helen E. Scott, Blaž Grošelj, et al.. (2014). Deoxycytidine Kinase Expression Underpins Response to Gemcitabine in Bladder Cancer. Clinical Cancer Research. 20(21). 5435–5445. 18 indexed citations
8.
Zecchini, Vincent, Basetti Madhu, Roslin Russell, et al.. (2014). Nuclear ARRB 1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer. The EMBO Journal. 33(12). 1365–1382. 51 indexed citations
9.
Sharma, Naomi L., Charles Massie, Falk Butter, et al.. (2014). The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer. Nucleic Acids Research. 42(10). 6256–6269. 29 indexed citations
10.
Sharma, Naomi L., Charles Massie, Antonio Ramos‐Montoya, et al.. (2012). The Androgen Receptor Induces a Distinct Transcriptional Program in Castration-Resistant Prostate Cancer in Man. Cancer Cell. 23(1). 35–47. 284 indexed citations
11.
Sharma, Neeti, Charlie E. Massie, Helen E. Scott, et al.. (2012). 942 The androgen receptor induces a distinct transcriptional program in castration resistant prostate cancer in man. European Urology Supplements. 11(1). e942–e942a. 5 indexed citations
12.
Vias, Maria, et al.. (2011). C-MYC induction of HES6 activates a distinct transcriptional network driving androgen insensitive prostate cancer. British journal of surgery. 98. 15–15. 1 indexed citations
13.
Veerakumarasivam, Abhi, Helen E. Scott, Suet‐Feung Chin, et al.. (2008). High-Resolution Array-Based Comparative Genomic Hybridization of Bladder Cancers Identifies Mouse Double Minute 4 ( MDM4 ) as an Amplification Target Exclusive of MDM2 and TP53. Clinical Cancer Research. 14(9). 2527–2534. 27 indexed citations
14.
Veerakumarasivam, Abhi, Leonard D. Goldstein, Kasra Saeb‐Parsy, et al.. (2008). AURKA overexpression accompanies dysregulation of DNA-damage response genes in invasive urothelial cell carcinoma. Cell Cycle. 7(22). 3525–3533. 13 indexed citations
15.
Vias, Maria, Charles Massie, Philip East, et al.. (2008). Pro-neural transcription factors as cancer markers. BMC Medical Genomics. 1(1). 17–17. 29 indexed citations
16.
Saeb‐Parsy, Kasra, et al.. (2008). Up-regulation of Flotillin 2 is associated with urothelial cell carcinoma progression. 101. 42–43. 1 indexed citations
17.
Anthony, Daniel C., John P. Lowe, Julian L. Griffin, et al.. (2007). MRI and MRS alterations in the preclinical phase of murine prion disease: Association with neuropathological and behavioural changes. Neurobiology of Disease. 26(3). 707–717. 29 indexed citations
18.
Boche, Delphine, Colm Cunningham, Fabián Docagne, Helen E. Scott, & V. Hugh Perry. (2006). TGFβ1 regulates the inflammatory response during chronic neurodegeneration. Neurobiology of Disease. 22(3). 638–650. 74 indexed citations
19.
Cunningham, Colm, Robert M. J. Deacon, H. Gideon Wells, et al.. (2003). Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. European Journal of Neuroscience. 17(10). 2147–2155. 222 indexed citations
20.
Bjørnland, Kristin, et al.. (1998). Polymorphonuclear elastase in human colorectal carcinoma.. International Journal of Oncology. 12(3). 535–40. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026